Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

被引：1
|
作者：
Alvarez, Ricardo H. [1 ]
Hortobagyi, Gabriel N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 124卷 / 03期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; INDUCTION CHEMOTHERAPY; PREDICTIVE MARKERS; DOXORUBICIN; SURVIVAL; WOMEN; CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10549-010-1212-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：701 / 705
页数：5
相关论文
共 50 条
  • [1] Should radiotherapy after primary systemic therapy be administered with the same recommendations made for operable breast cancer patients who receive surgery as first treatment? A critical review
    Allis, Simona
    Reali, Alessia
    Mortellaro, Gianluca
    Arcadipane, Francesca
    Bartoncini, Sara
    Redda, Maria Grazia Ruo
    TUMORI JOURNAL, 2012, 98 (05): : 543 - 549
  • [2] Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[ plus ] operable breast cancer
    Llombart-Cussac, Antonio
    Guerrero, Angel
    Galan, Antonio
    Caranana, Vicente
    Buch, Elvira
    Rodriguez-Lescure, Alvaro
    Ruiz, Amparo
    Fuster Diana, Carlos
    Guillem Porta, Vicente
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (02) : 125 - 131
  • [3] Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer
    Willsher, PC
    Robertson, JFR
    Jackson, L
    AlHilaly, M
    Blamey, RW
    BREAST, 1997, 6 (03) : 150 - 154
  • [4] Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy
    Bear, Harry D.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 607 - +
  • [5] Primary systemic therapy and whole breast irradiation for locally advanced breast cancer: A systematic review
    Kaidar-Person, Orit
    Kuten, Abraham
    Belkacemi, Yazid
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 92 (02) : 143 - 152
  • [6] Primary systemic chemotherapy of breast cancer: indication and predictive factors
    Jinno, Hiromitsu
    Sakata, Michio
    Hayashida, Tetsu
    Takahashi, Maiko
    Sato, Tomomi
    Seki, Hirohito
    Kitagawa, Yuko
    BREAST CANCER, 2011, 18 (02) : 74 - 79
  • [7] Prediction of response to primary chemotherapy for operable breast cancer
    Colleoni, M
    Orvieto, E
    Nolé, F
    Orlando, L
    Minchella, I
    Viale, G
    Peruzzotti, G
    Robertson, C
    Noberasco, C
    Galimberti, V
    Sacchini, V
    Veronesi, P
    Zurrida, S
    Orecchia, R
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) : 574 - 579
  • [8] Primary systemic therapy in breast cancer - an update for gynecologic oncologists
    Szekely, B.
    Szentmartoni, G.
    Kulka, J.
    Szasz, A. M.
    Langmar, Z.
    Dank, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (06) : 636 - 641
  • [9] Primary systemic therapy in HER2-amplified breast cancer: a clinical review
    Khasraw, Mustafa
    Bell, Richard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1005 - 1013
  • [10] Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial
    Lee, Keun Seok
    Ro, Jungsil
    Lee, Eun Sook
    Kang, Han Sung
    Kim, Seok Won
    Nam, Byung-Ho
    Kwon, Youngmee
    Kim, Eun-A
    Shin, Kyung Hwan
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (01) : 83 - 90
12345